Associate Professor Dr. Thomas Böldicke received his PhD 1982 at the Max-Planck-Institute of Molecular Genetics, Berlin. He started his carrier as post doc at the German Research Centre for Biotechnology (GBF, Braunschweig, Germany) in the Department of Genetics and Cell Biology by John Collins. Now he is project leader for Cancer Immunotherapy at the Helmholtz Centre for Infection Research (HZI, former GBF). He developed recombinant antibodies against tumor antigens, particularly against tumor angiogenesis, rhabdyomyosarcoma and recently against TLR2 and TLR9 in pancreatic cancer and has a collaboration with Prof. Waaga-Gasser in Medical School about adoptive T-cell therapy. He edited two books: “Protein Targeting Compounds” with Springer (2016) and “Antibody Engineering” with Intech Open (2017). He has published 28 manuscripts citated in Pub med. Over 10 years he gave lectures at the Technical University in Braun schweig about immunology, cancer development and immunotherapies. He is in the editorial board of the journal Antibodies as academic editor and co-editor in Frontiers in Immunology.

Michael Thompson is a Professor of the Department of Chemistry at the Universtiy of Toronto. The main thrust of research in the Thompson laboratory is the development of new techniques for the label-free detection of biochemical events at the liquid-solid interface. The goal is to generate new technologies for application in bioanalytical chemistry and detection science, notably in the areas of clinical diagnostics, biocompatibility and nanotoxiciology. The work is highly interdisciplinary in character and involves activities ranging from the design and construction of new instruments to theoretical calculations. Research staff possesses multidisciplinary expertise including such areas as basic electronics, surface chemistry, biochemistry, computational methods, and materials science.